Target intelligence / Profile preview

novel transcript, antisense to SIPA1L3

Molecular classification
Other
01

Overview

This entry refers to a predicted non-coding RNA transcript annotated on the antisense strand of the SIPA1L3 locus. There is no experimental evidence that this transcript encodes a functional protein or plays a recognized biological role. It is not considered a druggable target or known to participate in canonical molecular pathways. Most available information refers to its annotation status in genome databases, rather than any validated physiological or pathological function. ENSG00000268764 is a transcript annotated by Ensembl as "novel transcript, antisense to SIPA1L3", but there is no evidence that it encodes a protein or has any known biological or disease relevance. SIPA1L3 (ENSG00000105738), the sense gene, encodes a Rap GTPase-activating protein involved in lens morphogenesis and cellular adhesion, but the antisense transcript does not share these established functions[1][4][7]. The record is incomplete for drug discovery, lacking properties of a validated target, known biological function, or disease association, and therefore is not a therapeutic target.

Other names
ENSG00000268764

Beyond the preview

Go deeper on novel transcript, antisense to SIPA1L3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to SIPA1L3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call